Sturdivant v. Secretary of Health and Human Services

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 07-788V

(To be published)

*************************

*

DANA STURDIVANT and * Filed: January 21, 2016

TROY STURDIVANT, natural parents *

and guardians of B.G.S., a minor, *

*

Petitioners, * Vaccine Act Entitlement;

* Causation-in-fact; Autism;

v. * Prevnar; Hib; Table Injury

* Encephalopathy

SECRETARY OF HEALTH AND *

HUMAN SERVICES *

*

Respondent. *

*

*************************

Barrett J. Clisby, Oxford, MS, for the Petitioners.

Traci R. Patton, U.S. Department of Justice, Washington, DC, for the Respondent.

DECISION

HASTINGS, Special Master.

This is an action in which the Petitioners, Dana and Troy Sturdivant, seek an award under

the National Vaccine Injury Compensation Program (hereinafter the “Program”1), on behalf of

their son, B.G.S. Petitioners allege that Hib and Prevnar vaccinations administered to B.G.S. on

March 28, 2005, caused an encephalopathy in B.G.S., causing or contributing to his severe

neurodevelopmental disorder, and perhaps other problems. B.G.S. has been diagnosed as having

a neurodevelopmental disorder that falls within the category of an Autism Spectrum Disorder.

For the reasons set forth below, I conclude that the Petitioners are not entitled to an award on

behalf of B.G.S.

1

The applicable statutory provisions defining the Program are found at 42 U.S.C. § 300aa—10 et seq. (2012).

Hereinafter, for ease of citation, all “§” references will be to 42 U.S.C. (2012). I will also sometimes refer to the Act

of Congress that created the Program as the “Vaccine Act.”

1

I

THE APPLICABLE STATUTORY SCHEME

Under the National Vaccine Injury Compensation Program, compensation awards are

made to individuals who have suffered injuries after receiving vaccines. In general, to gain an

award, a petitioner must make a number of factual demonstrations, including showing that an

individual received a vaccination covered by the statute; received it in the United States; suffered

a serious, long-standing injury; and has received no previous award or settlement on account of

the injury. Finally – and the key question in most cases under the Program – the petitioner must

also establish a causal link between the vaccination and the injury. In some cases, the petitioner

may simply demonstrate the occurrence of what has been called a “Table Injury.” That is, it may

be shown that the vaccine recipient suffered an injury of the type enumerated in the “Vaccine

Injury Table,” corresponding to the vaccination in question, within an applicable time period

following the vaccination also specified in the Table. If so, the Table Injury is presumed to have

been caused by the vaccination, and the petitioner is automatically entitled to compensation,

unless it is affirmatively shown that the injury was caused by some factor other than the

vaccination. § 300aa-13(a)(1)(A); § 300aa-11(c)(1)(C)(i); § 300aa-14(a); § 300aa-13(a)(1)(B).

In other cases, however, the vaccine recipient may have suffered an injury not of the type

covered in the Vaccine Injury Table. In such instances, an alternative means exists to

demonstrate entitlement to a Program award. That is, the petitioner may gain an award by

showing that the recipient’s injury was “caused-in-fact” by the vaccination in question. § 300aa-

13(a)(1)(B); § 300aa-11(c)(1)(C)(ii). (“Causation-in-fact” is also known as “actual causation.”)

In such a situation, the presumptions available under the Vaccine Injury Table are inoperative.

The burden is on the petitioner to introduce evidence demonstrating that the vaccination initially

caused, or significantly aggravated, the injury in question. Althen v. HHS, 418 F.3d 1274, 1278

(Fed. Cir. 2005); Hines v. HHS, 940 F.2d 1518, 1525 (Fed. Cir. 1991). The showing of

“causation-in-fact” must satisfy the “preponderance of the evidence” standard, the same standard

ordinarily used in tort litigation. § 300aa-13(a)(1)(A); see also Althen, 418 F.3d at 1279; Hines,

940 F.2d at 1525. Under that standard, the petitioner must show that it is “more probable than

not” that the vaccination initially caused or aggravated the injury. Althen, 418 F.3d at 1279. The

petitioner need not show that the vaccination was the sole cause or even the predominant cause

of the injury or aggravation, but must demonstrate that the vaccination was at least a “substantial

factor” in causing or aggravating the condition, and was a “but for” cause. Shyface v. HHS, 165

F.3d 1344, 1352 (Fed. Cir. 1999). Thus, the petitioner must supply “proof of a logical sequence

of cause and effect showing that the vaccination was the reason for the injury;” and the logical

sequence must be supported by “reputable medical or scientific explanation, i.e., evidence in the

form of scientific studies or expert medical testimony.” Althen, 418 F.3d at 1278; Grant v. HHS,

956 F.2d 1144, 1148 (Fed. Cir. 1992).

The Althen court also provided additional discussion of the “causation-in-fact” standard,

as follows:

2

Concisely stated, Althen’s burden is to show by preponderant evidence that the

vaccination brought about her injury by providing: (1) a medical theory causally

connecting the vaccination and the injury; (2) a logical sequence of cause and

effect showing that the vaccination was the reason for the injury; and (3) a

showing of proximate temporal relationship between vaccination and injury. If

Althen satisfies this burden, she is “entitled to recover unless the [government]

shows, also by a preponderance of the evidence, that the injury was in fact caused

by factors unrelated to the vaccine.”

Althen, 418 F.3d at 1278 (citations omitted). The Althen court noted that a petitioner need not

necessarily supply evidence from medical literature supporting petitioner’s causation contention,

so long as the petitioner supplies the medical opinion of an expert. (Id. at 1279-80.) The court

also indicated that, in finding causation, a Program fact-finder may rely upon “circumstantial

evidence,” which the court found to be consistent with the “system created by Congress, in

which close calls regarding causation are resolved in favor of injured claimants.” (Id. at 1280.)

Since Althen, the Federal Circuit has addressed the causation-in-fact standard in several

additional rulings, which have affirmed the applicability of the Althen test, and afforded further

instruction for resolving causation-in-fact issues. In Capizzano v. HHS, 440 F.3d 1317, 1326

(Fed. Cir. 2006), the court cautioned Program fact-finders against narrowly construing the

second element of the Althen test, confirming that circumstantial evidence and medical opinion,

sometimes in the form of notations of treating physicians in the vaccinee’s medical records, may

in a particular case be sufficient to satisfy that second element of the Althen test. Both Pafford v.

HHS, 451 F.3d 1352, 1355 (Fed. Cir. 2006), and Walther v. HHS, 485 F.3d 1146, 1150 (Fed. Cir.

2007), discussed the issue of which party bears the burden of ruling out potential non-vaccine

causes. DeBazan v. HHS, 539 F.3d 1347 (Fed. Cir. 2008), concerned an issue of what evidence

the special master may consider in deciding the initial question of whether the petitioner has met

her causation burden. The issue of the temporal relationship between vaccination and the onset

of an alleged injury was further discussed in Locane v. HHS, 685 F.3d 1375 (Fed. Cir. 2012), and

W.C. v. HHS, 704 F.3d 1352 (Fed. Cir. 2013). Moberly v. HHS, 592 F.3d 1315 (Fed. Cir. 2010),

concluded that the “preponderance of the evidence” standard that applies to Vaccine Act cases is

the same as the standard used in traditional tort cases, so that conclusive proof involving medical

literature or epidemiology is not needed, but demonstration of causation must be more than

“plausible” or “possible.” Both Andreu v. HHS, 569 F.3d 1367 (Fed. Cir. 2009), and Porter v.

HHS, 663 F.3d 1242 (Fed. Cir. 2011), considered when a determination concerning an expert’s

credibility may reasonably affect the outcome of a causation inquiry. Broekelschen v. HHS, 618

F.3d 1339 (Fed. Cir. 2010), found that it was appropriate for a special master to determine the

reliability of a diagnosis before analyzing the likelihood of vaccine causation. Lombardi v. HHS,

656 F.3d 1343 (Fed. Cir. 2011), and Hibbard v. HHS, 698 F.3d 1355 (Fed. Cir. 2012), both again

explored the importance of assessing the accuracy of the diagnosis that supports a claimant’s

theory of causation. Doe 11 v. HHS, 601 F.3d 1349 (Fed. Cir. 2010) and Deribeaux v. HHS, 717

F.3d 1363 (Fed. Cir. 2013), both discuss the burden of proof necessary to establish that a “factor

unrelated” to a vaccine may have caused the alleged injury.

Another important aspect of the causation-in-fact case law under the Program concerns

the factors that a special master should consider in evaluating the reliability of expert testimony

3

and other scientific evidence relating to causation issues. In Daubert v. Merrell Dow

Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Supreme Court listed certain factors that federal

trial courts should utilize in evaluating proposed expert testimony concerning scientific issues.

In Terran v. HHS, 195 F.3d 1302, 1316 (Fed. Cir. 1999), the Federal Circuit ruled that it is

appropriate for special masters to utilize Daubert’s factors as a framework for evaluating the

reliability of causation-in-fact theories presented in Program cases.

II

BACKGROUND: THE OMNIBUS AUTISM PROCEEDING (“OAP”)

This case is one of more than 5,400 cases filed under the Program in which petitioners

alleged that conditions known as “autism” or “autism spectrum disorders” (“ASD”)2 were caused

by one or more vaccinations. A special proceeding known as the Omnibus Autism Proceeding

(“OAP”) was developed to manage these cases within the Office of Special Masters (“OSM”). A

detailed history of the controversy regarding vaccines and autism, along with a history of the

development of the OAP, was set forth in the six entitlement decisions issued as “test cases” for

two theories of causation litigated in the OAP (see cases cited below), and will only be

summarized here.

A group called the Petitioners’ Steering Committee (“PSC”) was formed in 2002 by the

many attorneys who represented Vaccine Act petitioners who raised autism-related claims.

About 180 attorneys participated in the PSC. Their responsibility was to develop any available

evidence indicating that vaccines could contribute to causing autism, and eventually present that

evidence in a series of “test cases,” exploring the issue of whether vaccines could cause autism,

and, if so, in what circumstances. Ultimately, the PSC selected groups of attorneys to present

evidence in two different sets of “test cases” during many weeks of trial in 2007 and 2008. In

the six test cases, the PSC presented two separate theories concerning the causation of ASDs.

The first theory alleged that the measles portion of the measles, mumps, rubella (“MMR”)

vaccine could cause ASDs. That theory was presented in three separate Program test cases

during several weeks of trial in 2007. The second theory alleged that the mercury contained in

thimerosal-containing vaccines could directly affect an infant’s brain, thereby substantially

contributing to the causation of ASD. That theory was presented in three additional test cases

during several weeks of trial in 2008.

Decisions in each of the three test cases pertaining to the PSC’s first theory rejected the

petitioners’ causation theories. Cedillo v. HHS, No. 98-916V, 2009 WL 331968 (Fed. Cl. Spec.

Mstr. Feb. 12, 2009) aff’d, 89 Fed. Cl. 158 (2009), aff’d, 617 F.3d 1328 (Fed. Cir. 2010);

Hazlehurst v. HHS, No. 03-654V, 2009 WL 332306 (Fed. Cl. Spec. Mstr. Feb. 12, 2009), aff’d

2

“Autism Spectrum Disorder” is a general classification which as of 2010 included five different specific disorders:

Autistic Disorder, Childhood Disintegrative Disorder, Asperger’s Syndrome, Rett Syndrome, and Pervasive

Developmental Disorder Not Otherwise Specified (PDD-NOS). King v. HHS, No. 03-584V, 2009 WL 892296 at *5

(Fed. Cl. Spec. Mstr. Feb. 12, 2010). The term “autism” is often utilized to encompass all of the types of disorders

falling within the autism spectrum. (Id.) I recognize that since the OAP test cases, the consensus description of

ASDs, contained now in the “DSM-V” as opposed to the prior “DSM-IV,” revises the prior subcategories of ASD

set forth in the first sentence of this footnote. However, the DSM-V retains the same general description of ASDs.

4

88 Fed. Cl. 473 (2009), aff’d, 604 F.3d 1343 (Fed. Cir. 2010); Snyder v. HHS, No. 01-162V,

2009 WL 332044 (Fed. Cl. Spec. Mstr. Feb. 12, 2009), aff’d, 88 Fed. Cl. 706 (2009).3 Decisions

in each of the three “test cases” pertaining to the PSC’s second theory also rejected the

petitioners’ causation theories, and the petitioners in each of those three cases chose not to

appeal. Dwyer v. HHS, No. 03-1202V, 2010 WL 892250 (Fed. Cl. Spec. Mstr. Mar. 12, 2010);

King v. HHS, No. 03-584V, 2010 WL 892296 (Fed. Cl. Spec. Mstr. Mar 12, 2010); Mead v.

HHS, No. 03-215V, 2010 WL 892248 (Fed. Cl. Spec. Mstr. Mar. 12, 2010).

The “test case” decisions were comprehensive, analyzing in detail all of the evidence

presented on both sides. The three test case decisions concerning the PSC’s first theory

(concerning the MMR vaccine) totaled more than 600 pages of detailed analysis, and were

solidly affirmed in many more pages of analysis in three different rulings by three different

judges of the United States Court of Federal Claims, and in two rulings by two separate panels of

the United States Court of Appeals for the Federal Circuit. The three special master decisions

concerning the PSC’s second theory (concerning vaccinations containing the preservative

“thimerosal”) were similarly comprehensive.

All told, the 11 lengthy written rulings by the special masters, the judges of the U.S.

Court of Federal Claims, and the panels of the U.S. Court of Appeals for the Federal Circuit

unanimously rejected the petitioners’ claims, finding no persuasive evidence that either the

MMR vaccine or thimerosal-containing vaccines could contribute in any way to the causation of

autism.

Thus, the proceedings in the six “test cases” concluded in 2010. Thereafter, the

Petitioners in this case, and the petitioners in other cases within the OAP, were instructed to

decide how to proceed with their own claims. The vast majority of those autism petitioners

elected either to withdraw their claims or, more commonly, to request that the special master

presiding over their case decide their case on the written record, uniformly resulting in a decision

rejecting the petitioner’s claim for lack of support. However, a small minority of the autism

petitioners have elected to continue to pursue their cases, seeking other causation theories and/or

other expert witnesses. A few such cases have gone to trial before a special master, and in the

cases of this type decided thus far, all have resulted in rejection of petitioners’ claims that

vaccines played a role in causing their child’s autism. See, e.g., Blake v. HHS, No. 03-31V, 2014

WL 2769979 (Fed. Cl. Spec. Mstr. Vowell May 21, 2014) (autism not caused by MMR

vaccination); Henderson v. HHS, No. 09-616V, 2012 WL 5194060 (Fed. Cl. Spec. Mstr. Vowell

Sept. 28, 2012) (autism not caused by pneumococcal vaccination); Franklin v. HHS, No. 99-

855V, 2013 WL 3755954 (Fed. Cl. Spec. Mstr. Hastings May 16, 2013) (MMR and other

vaccines found not to contribute to autism); Coombs v. HHS, No. 08-818V, 2014 WL 1677584

(Fed. Cl. Spec. Mstr. Hastings Apr. 8, 2014) (autism not caused by MMR or Varivax vaccines);

Long v. HHS, No. 08-792V, 2015 WL 1011740 (Fed. Cl. Spec. Mstr. Hastings Feb. 19, 2015)

(autism not caused by influenza vaccine); Brook v. HHS, No. 04-405V, 2015 WL 3799646 (Fed.

Cl. Spec. Mstr. Hastings May 14, 2015) (autism not caused by MMR or Varivax vaccines); Holt

v. HHS, No. 05-136V, 2015 WL 4381588 (Fed. Cl. Spec. Mstr. Vowell June 24, 2015) (autism

not caused by Hepatitis B vaccine); Lehner v. HHS, No. 08-554V, 2015 WL 5443461 (Fed. Cl.

Spec. Mstr. Vowell July 22, 2015) (autism not caused by influenza vaccine); Miller v. HHS, No.

3

The petitioners in Snyder did not appeal the decision of the U.S. Court of Federal Claims.

5

02-235V, 2015 WL 5456093 (Fed. Cl. Spec. Mstr. Vowell August 18, 2015) (ASD not caused by

combination of vaccines); Allen v. HHS, No. 02-1237V, 2015 WL 6160215 (Spec. Mstr. Vowell

Sept. 26, 2015) (autism not caused by MMR vaccination); R.K. v. HHS (Spec. Mstr. Vowell

Sept. 28, 2015) (autism not caused by influenza vaccine) (not yet published), aff’d by Judge

Braden on Dec. 18, 2015; Hardy v. HHS, No. 08-108V, 2015 WL 7732603 (Fed. Cl. Spec. Mstr.

Hastings Nov. 3, 2015) (autism not caused by several vaccines).

In addition, some autism causation claims have been rejected without trial, at times over

the petitioner’s objection, in light of the failure of the petitioner to file plausible proof of

vaccine-causation. See, e.g., Waddell v. HHS, No. 10-316V, 2012 WL 4829291 (Fed. Cl. Spec.

Mstr. Campbell-Smith Sept. 19, 2012) (autism not caused by MMR vaccination); Bushnell v.

HHS, No. 02-1648V, 2015 WL 4099824 (Fed. Cl. Spec. Mstr. Hastings June 12, 2015) (autism

not caused by multiple vaccines); Miller v. HHS, No. 06-753V (Fed. Cl. Spec. Mstr. Hastings

Sept. 25, 2012) (autism not caused by DTaP or MMR vaccines); Fesanco v. HHS, No. 02-

1770V, 2010 WL 4955721 (Fed. Cl. Spec. Mstr. Hastings Nov. 9, 2010); Fresco v. HHS, No. 06-

469V, 2013 WL 364723 (Fed. Cl. Spec. Mstr. Vowell Jan. 7, 2013); Pietrucha v. HHS, No. 00-

269V, 2014 WL 4538058 (Fed. Cl. Spec. Mstr. Hastings Aug. 22, 2014); Canuto v. HHS, No.

04-1128V, 2016 WL ____ (Fed. Cl. Spec. Mstr. Hastings Dec. 18, 2015) (on appeal). Judges of

this court have affirmed the practice of dismissal without trial in such a case. E.g., Fesanco v.

HHS, 99 Fed. Cl. 28 (Judge Braden affirming).

In none of the rulings since the test cases has a special master or judge found any merit in

an allegation that any vaccine can contribute to causing autism.4

4

I am well aware, of course, that during the years since the “test cases” were decided, in two cases involving

vaccinees suffering from ASDs, Vaccine Act compensation was granted. But in neither of those cases did the

Respondent concede, nor did a special master find, that there was any “causation-in-fact” connection between a

vaccination and the vaccinee’s ASD. Instead, in both cases it was conceded or found that the vaccinee displayed the

symptoms of a Table Injury within the Table time frame after vaccination. (See Section I above).

In Poling v. HHS, the presiding special master clarified that the family was compensated because the

Respondent conceded that the Poling child had suffered a Table Injury--not because the Respondent or the special

master had concluded that any vaccination had contributed to causing or aggravating the child’s ASD. See Poling v.

HHS, No. 02-1466V, 2011 WL 678559, at *1 (Fed. Cir Spec. Mstr. Jan. 28, 2011) (a fees decision, but noting

specifically that the case was compensated as a Table Injury).

Second, in Wright v. HHS, No. 12-423, 2015 WL 6665600 (Fed. Cl. Spec. Mstr. Vowell Sept. 21, 2015),

Special Master Vowell concluded that a child, later diagnosed with ASD, suffered a “Table Injury” after a

vaccination. However, she stressed that she was not finding that the vaccinee’s ASD in that case was “caused-in-

fact” by the vaccination--to the contrary, she specifically found that the evidence in that case did not support a

“causation-in-fact” claim, going so far as to remark that the petitioners’ “causation-in-fact” theory in that case was

“absurd.” (2015 WL 6665600 at *2.)

The compensation of those two cases, thus, does not afford any support to the notion that vaccinations can

contribute to the causation of autism. In setting up the Vaccine Act compensation system, Congress forthrightly

acknowledged that the Table Injury presumptions would result in compensation for some injuries that were not, in

fact, truly vaccine-caused. H.R. Rept. No. 99-908, 18, 1986 U.S.C.C.A.N. 6344, 6359. (“The Committee

recognizes that there is public debate over the incidence of illnesses that coincidentally occur within a short time of

vaccination. The Committee further recognizes that the deeming of a vaccine-relatedness adopted here may provide

compensation to some children whose illness is not, in fact, vaccine-related.”)

6

III

PROCEDURAL HISTORY OF THIS CASE

On November 9, 2007, Dana Sturdivant and Troy Sturdivant filed a petition (“Pet.”)

requesting compensation under the National Vaccine Injury Compensation Program, on behalf of

their son, B.G.S. Various medical records were attached to that petition, identified as

Petitioners’ Exhibit A (“Pet. Ex. A”). The petition alleged that a measles-mumps-rubella

vaccination administered to B.G.S. on November 29, 2004, acting either alone or in combination

with the Hib (haemophilus influenza type B) and Prevnar (pneumococcal) vaccinations

administered to B.G.S. on March 28, 2005, caused his neurological, gastrointestinal, metabolic,

and allergy problems. (Pet., ¶1.) Petitioners filed additional medical records, identified as

Petitioners’ Exhibit B (“Pet. Ex. B”), on April 8, 2008.

Initially, the case was assigned to Special Master Richard Abell. (ECF No. 2.)

Petitioners filed a request, on May 29, 2008, to transfer the case to the Omnibus Autism

Proceeding (“OAP”). That request was granted on June 5, 2008, and the case was re-assigned to

the docket of Chief Special Master Golkiewicz. (ECF Nos. 9-10.) However, on June 12, 2009,

Petitioners filed a request for “Review of Case-Specific Proof of Causation,” indicating that they

did not want their petition linked to other cases. On July 10, 2009, Chief Special Master

Golkiewicz granted their request, “de-coupled” this case from the OAP, and reassigned it to the

docket of Special Master Sandra Lord. (ECF Nos. 11, 14.)

Petitioners filed additional medical records identified as Petitioners’ Exhibit C (“Pet. Ex.

C”), on August 3, 2009.

On November 2, 2009, Respondent filed Respondent’s Report, contending that this claim

is not eligible for compensation. (ECF No. 16, p. 2.)

On November 16, 2010, this case was reassigned to the docket of Special Master Patricia

Campbell-Smith. (ECF No. 24.)

On January 17, 2011, Petitioners filed the medical records of Dr. John Shoffner, director

of the Medical Neurogenetics (“MNG”) laboratory.5 Petitioners filed a Notice of their intent to

remain in the Vaccine Injury Compensation Program, on June 21, 2011. On October 14, 2011,

Petitioners filed an Amended Petition. In that Amended Petition, the Petitioners alleged that “the

Hib vaccine is the cause-in-fact of [B.G.S.’s] current complications and deficiencies.” (p. 2, ¶ 6.)

Confusingly, however they also alleged that “as a direct result of one or combination” of the

Prevnar and Hib vaccinations, B.G.S. suffered multiple neurological and gastrointestinal

problems. (Id., p. 3, ¶ 7.) Further, Petitioners contended that B.G.S. “reacted to the Hib within

72 hours” after receiving the vaccination. (Id., p. 3, ¶ 8.) On June 28, 2012, Petitioners filed the

expert medical opinion of Dr. Stephen Chevalier, Petitioners’ Ex. D (“Pet. Ex. D.”)

5

These medical records were not assigned an exhibit number or letter. I will refer to them as the “MNG records.”

7

Respondent filed the expert report of Dr. Peter Bingham, Respondent’s Exhibit A (“R.

Ex. A”), on November 8, 2012.6

On March 8, 2013, this case was reassigned to my docket. (ECF No. 39.) I convened a

telephonic status conference on May 20, 2013, to address the difficulties presented by certain

illegible entries in Dr. Chevalier’s office records. Petitioners were instructed to provide a legible

transcript of these important entries. (See Order, May 20, 2013.)

It took over a year, but Petitioners finally filed the typewritten transcription of various

medical notes recorded by Dr. Chevalier (“Pet. Ex. F”), and a supplemental expert report of Dr.

Chevalier (“Pet. Ex. E”), on May 29, 2014.

After filing their exhibits E and F, Petitioners continued to seek additional medical

records. (See ECF Nos. 52-63.) On January 20, 2015, Petitioners filed a status report indicating

that they were ready to proceed to a trial in this case. (ECF No. 64.) During a status conference

on January 27, 2015, and via documents filed over the next several months, the parties prepared

for an evidentiary hearing to be held on July 31, 2015, at which the Petitioners themselves, other

family members, Dr. Chevalier, and Dr. Bingham would testify. (ECF Nos. 65-74.)

However, during a status conference held on July 28, 2015, Petitioners’ counsel informed

me that Dr. Chevalier was no longer willing to testify in the case, and that Petitioners wished to

submit the case to me without oral expert testimony. Respondent’s counsel agreed. (ECF No.

76.)

Accordingly, during the evidentiary hearing on July 31, 2015, the only witnesses offered

by Petitioners were the Petitioners and two of the grandparents of B.G.S. (Tr. 1-117.) At the

conclusion of the hearing, Petitioners’ counsel clarified that they were submitting the case to me,

relying upon the testimony of the four lay witnesses who testified that day, plus the two written

expert reports of Dr. Chevalier. (Tr. 119-20.) Petitioners’ counsel waived the right to file post-

hearing briefs (Tr. 120-21), instead electing to make a brief closing argument. (Tr. 121-23.)

IV

FACTS

Petitioners’ son, B.G.S., was born on November 21, 2003. (Pet. Ex. A, p. 23.) His

medical records indicate that B.G.S. received regular pediatric examinations and immunizations

during his first 12 months of life. (Pet. Ex. A, pp. 25-28, 79.)

On November 29, 2004, when B.G.S. was 12 months old, he received his first MMR and

varicella vaccinations, along with his fourth diphtheria-tetanus-acellular pertussis (“DTaP”)

vaccination. On that date, his pediatrician noted B.G.S.’s developmental progress as: “takes 3

steps, 4 words, feeds self well.” (Pet. Ex. A, pp. 31, 79).

6

Both Petitioners and Respondent used letters of the alphabet to identify their exhibits. Respondent’s filing on

November 8, 2012, included Respondent’s Exhibits A, B, C, D, and E.

8

At 13 months of age, on December 23, 2004, B.G.S. was prescribed the antibiotic

Augmentin, to treat an episode of left otitis media. He was re-examined six days later on

December 29, when his mother reported that he had vomited several doses of the antibiotic. The

examining nurse noted that B.G.S. would receive three more days of antibiotic treatment. (Pet.

Ex. A, p. 32.)

Three months later, on March 28, 2005, B.G.S.’s developmental progress was described

as “runs, climbs, 5-10 words, understands, follows commands, uses spoon, scribbles, stacks.”

According to the office notes, he “eats well” and he is “doing well.” (Pet. Ex. A, p. 33; Pet. Ex.

F, p. 1.) On that date, B.G.S. received his fourth Prevnar and his third Hib vaccinations. (Pet.

Ex. A, pp. 33, 79.)

On March 30, 2005, B.G.S. returned to his pediatrician with a temperature of 100.9°,

suffering from two days of fever up to 103°, nausea, vomiting, and diarrhea. His pediatrician

noted that B.G.S. wanted to eat and drink, that his nausea and vomiting had decreased, and that

he was “happy and not in acute distress.” His oropharynx and tympanic membranes were

described as “clear.” The assessment by B.G.S.’s pediatrician indicated “gastroenteritis,” which

was treated with Motrin and Tylenol. (Pet. Ex. A, p. 34; Pet. Ex. F, p. 2.)

The following day, on March 31, 2005, B.G.S. returned to his doctor’s office with a “3

day history of fever up to 104° [for] two days,” and loose stools. He had “normal urine output”

and, again, both of his ears were “clear,” and his oropharynx was “benign.” The assessment at

that time was “viral illness – gastroenteritis,” which was treated by the administration of

appropriate fluids and nutrition. (Pet. Ex. A, p. 35; Pet. Ex. F, p. 3.)

Eleven days later, on April 11, 2005, B.G.S. returned to his pediatrician with a three-day

history of fever, reaching a maximum of 103.9°, along with a cough, congestion and fussiness.

His physical examination revealed bilateral otitis media, with bulging, dull tympanic membranes

that exhibited zero movement. He received an injection of Rocephin, and a ten-day prescription

of Augmentin. (Pet. Ex. A, p. 36; Pet. Ex. F, p. 4). On April 12 and 13, 2005, B.G.S. returned to

his pediatrician’s office to receive repeat injections of Rocephin. (Id.)

There are no further pediatric notes for seven months, until November 7, 2005, when

B.G.S. received an influenza vaccination. On November 29, 2005, B.G.S. was examined by his

pediatrician, who noted that he spoke only 5 to 6 words, and might have difficulty hearing. The

pediatrician suspected “delayed speech,” and made referrals for speech and hearing evaluations.

One such referral, to the “First Steps” program for evaluation, was cancelled by B.G.S.’s mother.

(Pet. Ex. A, pp. 37-38.)

On December 6, 2005, B.G.S. was seen at the ENT Clinic of the University of

Mississippi Medical Center, where the physician performing the exam noted that the parents “do

not feel that [B.G.S.’s] speech is normal for his age.” The doctor also indicated that

“[o]therwise, [B.G.S.] seems to be developmentally appropriate to his parents.” (Pet. Ex. A, p.

61.) Dr. Kyle Gordon, a pediatric otolaryngologist at the Ear Nose & Throat Surgical Group,

evaluated B.G.S. for possible hearing loss on December 15, 2005, when he was 25 months old.

9

At that time, his parents reported that “they do not feel that his speech is normal for his age…that

he says a few words and babbles a lot.” Based on evidence that B.G.S. possibly suffered from

“conductive hearing loss bilaterally,” Dr. Gordon discussed with his parents the possibility of

inserting bilateral “PE tubes” (pressure equalization tubes) in his ears. However, B.G.S.’s

parents were reluctant to do so at that time. (Id., p. 60.)

Four months later, on March 31, 2006, B.G.S. received treatment for fever, coughing, and

left otitis media (ear infection). (Pet. Ex. A, p. 39.) He later received another hearing evaluation

from a clinical audiologist at the Jackson Ear Clinic, on April 3, 2006, at which time his mother

reported that B.G.S. “had a severe ear infection in April 2005, and since that time [the mother]

feels that hearing has not been as good, and he has quit talking.” The audiologist stated that

B.G.S. possessed “hearing sensitivity in the normal to near normal range for at least one ear” that

would be “sufficient for normal speech and language development.” (Pet. Ex. B, p. 3.)

Pediatrician Steven Chevalier referred B.G.S. to “Beyond Play Therapy” for evaluation

of pervasive developmental disorder (“PDD”) on July 18, 2006. On July 26, 2006, B.G.S.

received approval for twice-weekly speech therapy. (Pet. Ex. A, pp. 39-40.)

The Rankin County School District performed a speech and development evaluation on

B.G.S. on November 16 and December 7, 2006. At that time, his parents reported that he “was

developing normally until approximately 18 months of age, when his language skills regressed

significantly and he stopped using words.” The evaluators concluded that B.G.S. exhibited “a

25% or more delay in the developmental areas of language, social and cognitive” performance.

This developmental level “fell within the mild to moderate autistic range.” (Pet. Ex. A, pp. 93,

96, 98.)

On March 30, 2007, B.G.S. suffered another episode of fever and bilateral otitis media

that required treatment with antibiotics. He received further treatment for persistent fevers on

April 1, 2007. His parents brought him to the Baptist Hospital Emergency Center in Jackson, on

April 2, 2007, because he had a fever, was jaundiced, and his urine was brown colored. Medical

personnel at Baptist Hospital concluded that B.G.S. suffered from hemolytic anemia, and treated

him with intravenous fluids. On April 4, 2007, B.G.S. was transferred to the University of

Mississippi Medical Center, in Jackson, for further evaluation. It was noted that B.G.S. had

previously received two injections of Rocephin, but “he continued with increased temp

[reportedly 104°]. He was then more lethargic and had ‘?convulsions’ with fever.” The hospital

notes suggest that his urine discoloration might be attributed to weekly DMSA “chelation”

treatments that he had been receiving. The hospital summary of B.G.S.’s treatment, dated April

5, 2007, lists his diagnoses as: “autism; autoimmune hemolytic anemia; febrile illness, resolved.”

(Pet. Ex. A, pp. 41, 55-56.)

On April 6, 2007, B.G.S.’s parents returned to their pediatrician, complaining that he still

suffered from fever and urine problems. Dr. Chevalier closely monitored B.G.S.’s recovery from

hemolytic anemia, recording his observations on April 6, 9, 12, and 19 of 2007. (Pet. Ex. A, pp.

43-44.)

10

Petitioners brought B.G.S. to the Mississippi Behavior Clinic to obtain a second opinion

regarding his developmental problems. On August 20, 2007, these specialists described his

symptoms in great detail and confirmed his diagnosis of “autism,” specifically citing the

diagnostic code for autistic disorder (299) from the DSM-IV-TR. This report briefly

summarized an interview with B.G.S.’s parents, in which they indicated that, “after having

received his immunizations at 16 months of age, progression of his milestones ceased… he

stopped talking and began to display extreme social changes.” (Pet. Ex. B, pp. 32-33.)

On May 14, 2008, a video-EEG examination was administered to B.G.S. to evaluate

possible seizure activity. Certain “eye fluttering” events were reported, but these were not

associated with any epileptiform discharges during the test. There were, however, “generalized

epileptiform discharges during sleep.” (Pet. Ex. C, p. 67.)

On June 10, 2008, Dr. Anne Yates, a pediatric allergy and immunology specialist at the

University of Mississippi Medical Center, examined B.G.S. Dr. Yates noted the history reported

by B.G.S.’s mother that: “within 7 weeks after his MMR, varicella and DTaP vaccines (given

11/29/04),7 he began to have less social interaction, and less speech and language development”

… and “[i]nitially, these changes were quite subtle.” (Pet. Ex. C, p. 150.) Dr. Yates summarized

her impressions, which included “autistic child, of unknown etiology,” a history of mild rhinitis,

rashes, occasional infections, and numerous food intolerances without any evidence of “true IgE-

mediated allergic reaction.” (Id., p. 153.) Based on laboratory testing, she confirmed that B.G.S.

had protective titers to Hib, diphtheria, Polio, varicella, measles, rubella, hepatitis B and herpes

virus 6. She noted inadequate titer levels for mumps and tetanus, and recommended

administration of the pneumovax vaccine and a DTaP booster. (Id., pp. 107, 153.) However,

B.G.S.’s mother indicated that she did not want him to receive further vaccinations. (Id., p. 106.)

In April 2008, specialists at the Biochemical Genetics Laboratory of the University of

Mississippi Medical Center performed extensive tests on B.G.S. to identify any potential genetic

causes of his condition. Dr. Hans Bock’s impression after the testing was, “I have documented

no definite evidence to support a possible mitochondrial etiology.” (Pet. Ex. C, pp. 64-65.)

Dr. Colette Parker, a pediatric neurologist at the University of Mississippi Medical

Center, summarized B.G.S.’s medical status in a report on April 29, 2009. She recorded the

impression that B.G.S. suffered from “static encephalopathy,” “autistic spectrum disorder,” and

some epileptiform activity. She also noted that an extensive genetic evaluation of B.G.S.

performed was “thus far negative.” (Pet. Ex. C, pp. 61-62.)

7

MMR, varicella, and DTaP vaccinations were administered on November 29, 2004, as noted in this quotation. The

alleged onset of various “subtle” symptoms, “within seven weeks” of that date, would have occurred in late January,

2005. I note that there are no medical records pertaining to January and February 2005. The symptoms mentioned

in this quote were not described in the office notes concerning the next medical examination, on March 28, 2005.

The Prevnar and Hib vaccinations were administered on March 28, 2005.

11

V

SUMMARY OF EXPERT WITNESSES’ QUALIFICATIONS AND OPINIONS

In this case, Petitioners relied upon the expert reports of a single medical expert, as did

Respondent. Initial prehearing discussions indicated that Petitioners’ expert, Dr. Chevalier,

would orally testify on behalf of Petitioners, but the Petitioners ultimately elected to rely only on

his expert reports. Both parties were amenable to the reports of their experts being used in this

manner. At this point, I will briefly summarize both the qualifications and the opinions of these

expert witnesses.

A. Petitioners’ expert

1. Qualifications of Steven Chevalier, M.D.

Dr. Chevalier is a board-certified pediatrician who provided medical care for B.G.S. from

birth through mid-2012. (Pet. Exs. D, E.) Petitioners did not file a curriculum vitae, or a

description of Dr. Chevalier’s qualifications.8

2. Summary of the opinion of Steven Chevalier, M.D.

Petitioners filed their Amended Petition on October 14, 2011, introducing various

changes in their theory of vaccine causation. One change of particular significance is that

“petitioners aver that Hib vaccine is the cause-in-fact of [B.G.S.’s] current complications and

deficiencies.” (Am. Pet., pp. 2-3, ¶ 6.) Further, B.G.S. “reacted to the Hib within 72 hours.”

(Id., ¶ 8.) Thus, the Amended Petition does not implicate the MMR vaccine as a cause of

B.G.S.’s condition, and petitioners now allege vaccine “causation-in-fact” rather than a “Table

Injury.”

In support of that Amended Petition, two affidavits of Dr. Chevalier were filed:

Petitioners’ Exhibit D and E. Neither of Dr. Chevalier’s affidavits (expert reports) includes

mention of a “Table Injury.”

According to his first report, filed on June 28, 2012, Dr. Chevalier was B.G.S.’s

pediatrician from birth until mid-2012, when the family moved to Florida. Dr. Chevalier stated

that B.G.S.’s development from birth until late March 2005 “was on a completely normal

course.” Dr. Chevalier also stated that, following B.G.S.’s vaccinations on March 28, 2005 - -

[B.G.S.] developed a fever up to 104 and an acute rash. Within (3) days he

continued to appear ill and was admitted [to] the Mississippi Baptist Medical

Center appearing jaundiced, lethargic and experiencing abnormal urine. All of

8

I note that the first expert report of Dr. Chevalier, filed June 28, 2012, states that “a curriculum vitae is included in

Exhibit “A” which contains a report outlining Steven P. Chevalier, M.D., FAAP qualifications and expertise.” (Pet.

Ex. D, p. 2.) However, there are no page numbers cited, and my review of Pet. Ex. A did not reveal a curriculum

vitae.

12

this started and progressed within seventy-two (72) hours of the injection and has

continued… Following his hospitalization for acute changes, [B.G.S.’s]

development slowed, his speech regressed, and his socialization skills severely

regressed. From this time forward, [B.G.S.] has had significant issues consistent

with a severe pervasive developmental disorder. It is my professional opinion,

stated to a reasonable degree of medical certainty, that the Encephalopathy

commenced within seventy-two (72) hours of the DTaP/Hib injection and

persisted for more than twenty-four (24) hours in this child.

(Pet. Ex. D, p. 2.)

The second report of Dr. Chevalier, filed on May 19, 2014, is largely a repetition of his

earlier report, but contained a few modifications. Dr. Chevalier wrote:

On March 28, 2005, [B.G.S.] received a Prevnar vaccine and a Hib vaccine

(haemophilus influenza type B). Immediately after the shots were administered

[B.G.S.] began to show raised, red bumps around the injection sites. That night,

he was reported as restless with a high fever, which continued the next day along

with diarrhea. [B.G.S.’s] fever reached 104 within three days of receiving the

vaccinations and the injection sites had become an acute rash. [B.G.S.] also had

some convulsions, seizures and other forms of ataxia in that short time frame as

well. Spiking fever, rash, and seizures are three large red flags of

encephalopathy, which I diagnosed in this child. Within three (3) days he

continued to appear ill and was admitted to Mississippi Baptist Medical Center on

March 30, 2005 appearing lethargic, with decreased appetite, and high fever. All

of this started and progressed within seventy-two (72) hours of the injection and

has continued.

(Pet. Ex. E, p. 2.)

Dr. Chevalier described B.G.S.’s gradually worsening developmental delay following March of

2005. He stated that:

It is undeniable, to a reasonable degree of medical certainty, that this child

experienced irreversible injury which occurred proximate to the Hib and Prevnar

vaccinations with onset of symptoms within a less than four hour time frame.

(Id.) Dr. Chevalier concluded with his professional opinion stating, with a reasonable degree of

medical certainty, that “the encephalopathy commenced within seventy-two (72) hours of the

Hib and Prevnar injections and persisted for more than twenty-four (24) hours in this child.”

(Id., p. 3.)

Thus, in both of Dr. Chevalier’s affidavits, it appears that his theory of vaccine causation

amounts to a suggestion that the vaccinations administered on March 28, 2005, caused B.G.S. to

have an “encephalopathy” that manifested within seventy-two hours following those

13

vaccinations. The report also suggests that such encephalopathy resulted in an unspecified

“irreversible injury” to B.G.S. thereafter. (Ex. E, p. 2.)

B. Respondent’s expert

1. Qualifications of Peter Bingham, M.D.

In 1981, Peter Bingham graduated, cum laude, from Harvard College with a bachelor’s

degree in biology. Dr. Bingham received his medical degree from the Columbia College of

Physicians & Surgeons, in New York, in 1987. He performed a pediatrics residency at the

Children’s Hospital of Philadelphia from 1987 to 1989. From 1989 until 1992, he served as a

Neurology Resident at the Children’s Hospital of Philadelphia and the Hospital of the University

of Pennsylvania, in Philadelphia. In 1994, he completed a one-year neuromuscular disease

research fellowship at the Hospital of the University of Pennsylvania. (R. Ex. B, p. 1.)

Between 1994 and 2000, Dr. Bingham was an Assistant Professor of Neurology and

Pediatrics at the University of Pennsylvania School of Medicine. Concurrently, he served as a

staff physician at the Children’s Hospital of Philadelphia, where he participated in inpatient

services and the general child neurology clinic. He was appointed Associate Professor of

Neurology and Pediatrics at the University of Vermont, in August 2000, and became a staff

physician in pediatric neurology at Fletcher Allen Health Care/University of Vermont, at the

same time. As of November 2012, Dr. Bingham continued to serve in both of those positions.

Dr. Bingham has been board-certified in Neurology and Child Neurology since 2005. (R. Ex. B,

pp. 1-2.)

Dr. Bingham has published thirty peer-reviewed medical articles. He has also written or

co-authored all or parts of more than ten textbooks concerning neurology or pediatrics. (R. Ex.

B, pp. 3-6.)

2. Summary of the opinion of Peter Bingham, M.D.

Respondent filed the expert report of Dr. Peter Bingham on November 8, 2012. Dr.

Bingham opined that although B.G.S. has a form of autism, his neurodevelopmental difficulties

did not result from vaccinations that he received on March 28, 2005. (R. Ex. A, p. 4.) In his

initial review of the facts of this case, Dr. Bingham noted that B.G.S. had a history of benign

“macrocrania” (an unusually large head) for the first three months of life and beyond. (Id., p. 1,

citing Pet. Ex. A, p. 66.) He contended that this unusual head growth was the antecedent of

autism, suggesting a genetic or pre-natal origin of B.G.S.’s condition. (Id., p. 5.)

Dr. Bingham strongly contested the factual basis for Petitioners’ assertion that B.G.S.

suffered an acute encephalopathy in the days and weeks following his vaccinations of March 28,

2005. He explained that the medical records following that date do not contain any mention of a

rapid decrease in consciousness (that is, lethargy, stupor or coma), disorientation, or seizures,

which are the clinical characteristics of an acute encephalopathy. Dr. Bingham alleges that there

are multiple inaccuracies in the summaries of B.G.S.’s medical history that were provided in the

Petitioners’ affidavits and the assumptions made by Dr. Chevalier. (R. Ex. A, pp. 4-5.)

14

Dr. Bingham also observed that Petitioners and their expert have not set forth any

description of a biological mechanism that might link any of B.G.S.’s vaccinations to

developmental impairment or autism. (R. Ex. A, p. 5, ¶ 3.) He also contended that the medical

records do not support Petitioners’ contentions regarding B.G.S.’s gastrointestinal or metabolic

disturbances. (Id., ¶ 5.) Dr. Bingham concluded with a sharp disagreement with Dr. Chevalier’s

understanding of the events following B.G.S.’s vaccination, which was not supported by

contemporaneously-recorded medical records. (Id., pp. 5-6.)

VI

ISSUES TO BE DECIDED

Unfortunately, it is not completely clear exactly what Petitioners are arguing in this case.

For example, as will be detailed below (see Section VII of this Decision), Petitioners’ counsel

was not even completely clear as to what vaccinations he alleged to have harmed B.G.S. Also,

while Dr. Chevalier’s two reports do not even mention a “Table Injury,” Petitioners’ counsel at

the conclusion of the hearing seemed to argue briefly, though confusingly, that B.G.S. suffered a

“Table Injury encephalopathy.” Further, it is not even clear what injury of B.G.S. it is that

Petitioners seek compensation for. That is, their counsel insisted during his brief closing

argument that this case “is not an autism case” and that “autism is not a problem with this child.”

(Tr. 122.) Yet, the most basic point of the Petitioners’ case seems to be to seek compensation for

B.G.S.’s severe neurodevelopmental disorder (see Petitioners’ Amended Petition and

Petitioners’ Prehearing Memorandum), which disorder has in fact been diagnosed as falling

within the autism spectrum. (See, e.g., Pet. Ex. A, pp. 55-56, 96.) In addition, while Petitioners

have asserted that his vaccinations of March 28, 2005, caused not only his neurological

deficiencies, but also “gastrointestinal disorders,” “metabolic disorders,” and “food allergies”

(see their Petition, Amended Petition, and Prehearing Memorandum), their expert’s two reports

said nothing about the latter three types of disorders, asserting only that B.G.S. suffered from

“encephalopathy.”

This Decision, accordingly, will be organized according to the two general theories of

vaccine causation which seem to have been advocated by Petitioners, in their expert’s two

reports and in their counsel’s closing argument. Specifically, the two primary issues to be

decided here are: 1) whether B.G.S. suffered a “Table Injury encephalopathy;” and 2) whether,

as Petitioners alternatively argue, B.G.S.’s vaccinations of March 28, 2005, played any role in

“causing-in-fact” his neurodevelopmental disorder (or any other injuries).

15

VII

TABLE INJURY

Petitioners’ counsel very briefly argued orally that B.G.S. suffered a “table injury” based

upon the administration of the Prevnar and Hib vaccinations, on March 28, 2005. (Tr. 121.)

However, I find this argument to be completely without merit.

First, counsel’s two-paragraph argument about an alleged “table injury” was far from

clear, as to even what counsel was arguing. (Tr. 121, lines 7-22.) Counsel did not even specify

what Table Injury he alleged to have occurred. In his second sentence, counsel accurately stated

that B.G.S. received, on March 28, 2005, Prevnar and Hib vaccinations. But in his first and third

sentences counsel mentioned a “DTP-Hib” shot and a “DTP and Hib simultaneously.” (Tr. 121,

lines 7-9, 13-16).

This argument was simply incoherent. But if counsel was arguing that B.G.S. actually

received a DTP shot on March 28, 2005, he was flatly wrong, as the records make clear. (Pet.

Ex. A, p. 34; Pet. Ex. F, p. 1.)

Guessing at what counsel was suggesting, he may have been acknowledging in his first

paragraph that B.G.S. did not receive a DTP vaccination on March 28, 2005, but arguing that I

should, for unexplained reasons, treat B.G.S.’s case as if a DTP vaccination had occurred on that

day. (Tr. 121, lines 7-16.) Note that in his following paragraph, counsel states that Dr.

Chevalier opined that B.G.S. had suffered an “encephalopathy” commencing within 72 hours of

his March 28 vaccinations. (Tr. 121, lines 17-22.) Note also that “encephalopathy” is listed on

the applicable Vaccine Injury Table as a Table Injury for the DTP vaccine, but is not listed as a

Table Injury for the Hib or Prevnar (pneumococcal) vaccinations. (See 42 C.F.R. § 100.3 - -

compare section (a) II (encephalopathy listed as a Table Injury for DTP vaccine) to sections IX

and XII (no Table Injuries at all listed for the Hib and pneumococcal vaccines).)9

But if that was, in fact, what petitioners’ counsel meant to suggest, I must reject that

argument completely. Encephalopathy is simply not a Table Injury for either the Hib or Prevnar

vaccines, so by law I cannot apply the “Table Injury encephalopathy” standards to B.G.S.’s case.

9

The statute itself contains a version of the Vaccine Injury Table that applied to vaccinations administered prior to

the enactment of the Program and for several years after that enactment. See § 300aa-14(a). However, the Vaccine

Injury Table was administratively modified with respect to Program petitions, such as this one, that were filed after

March 24, 1997. See 62 Fed. Reg. 7685, 7688 (1997); O’Connell v. Shalala, 79 F.3d 170 (1st Cir. 1996). That

Table modification, along with an earlier administrative modification of the Table in 1995 (see 60 Fed. Reg. 7694

(1995)), significantly altered the “Table Injury” categories, with respect to pertussis-containing or measles-

containing vaccinations, from the version of the Table contained in the statute. The revised Table, listing

“encephalopathy” as a Table Injury for the pertussis-containing (DTP) vaccinations, but not Hib or pneumococcal

vaccinations, appears at 42 C.F.R. § 100.3 (2015 edition of C.F.R.). (I note also that in each Program case, the

version of the Vaccine Injury Table applicable to the case is the version that was in effect on the date on which the

petition was filed. (§ 14(c)(4).) The petition in this case was filed on November 9, 2007, so the version of the

Vaccine Injury Table applicable to this case is the one that existed in the Code of Federal Regulations on that date.

That is the version that I describe in the text above.)

16

And in any event, even if “encephalopathy” was a Table Injury applicable to B.G.S.’s

case, the evidence would still not show that B.G.S. suffered a “Table Encephalopathy.” That is,

for Vaccine Act petitions, such as this one, filed after the modifications to the Vaccine Injury

Table in effect since 1995 and 1997, “encephalopathy” exists as a Table Injury for several

vaccinations (pertussis-containing or measles–containing), but a lengthy, precise definition of a

“Table encephalopathy” is specified. 42 C.F.R. § 100.3(b)(2). The regulation, to summarize,

requires a “significantly decreased level of consciousness” that lasted at least 24 hours. As noted

in Waddell, by then-Chief Special Master Campbell-Smith, that regulatory definition implies “a

state of diminished alertness that is much more than mere sleepiness or inattentiveness . . . [It]

requires markedly impaired--or strikingly absent--responsiveness to environmental or external

stimuli, for a sustained period of at least twenty-four hours.” Waddell v. HHS, No. 10-316V,

2012 WL 4829291, at *7 (Fed. Cl. Spec. Mstr. Sept. 19, 2012). Special Master Campbell-Smith

added that the symptoms of a “Table Injury encephalopathy” are not “subtle.” (Id. at *6.)

The medical records of this case, however, show no such injury. To the contrary, the

records show that on March 30, 2005, B.G.S., while feverish and having suffered from some

nausea and vomiting, was “happy and not in acute distress.” (Pet. Ex. A, p. 34; Pet. Ex. F, p. 2.)

Accordingly, Petitioners’ argument that B.G.S. suffered a Table Injury must be rejected.10

VIII

PETITIONERS HAVE NOT SHOWN THAT B.G.S. SUFFERED ANY INJURY

THAT WAS “CAUSED-IN-FACT” BY HIS VACCINATIONS OF MARCH 28, 2005

Second, I conclude that Petitioners have failed to demonstrate that it is “more probable

than not” that B.G.S. suffered any injury that was “caused-in-fact” by his vaccinations of March

28, 2005 (or any other vaccinations). There are several reasons for this conclusion.

A. Petitioners’ and Dr. Chevalier’s conclusions are based on incorrect assumptions as

to B.G.S.’s medical history.

As noted above, Dr. Chevalier opined, in both of his written reports, that B.G.S. suffered

an “encephalopathy,” and “irreversible injury,” within 72 hours of his vaccinations of March 28,

10

In this regard, I note that, though Petitioners’ counsel never referred to it in the Petition, the Amended Petition, the

Prehearing Memorandum, or his closing argument, I found in the medical records of B.G.S. a document which

mentions a “Table Injury.” That is, the records include a letter of a medical doctor, Jerry Kartzinel, who opined that

B.G.S. had suffered a “TABLE INJURY following his March 28, 2005 vaccinations, which resulted in vaccine

induced encepahalopathic changes.” (Pet. Ex. C, p. 154) (capitals in the original.) However, Dr. Kartzinel, also did

not explain what Table Injury he was describing, nor explain why he believed that B.G.S suffered any Table Injury.

Again because, as explained above, the Vaccine Injury Table does not even list any Table Injuries for the Hib or

Prevnar vaccines, I find no merit to this reference of Dr. Kartzinel.

17

2005.11 (Pet. Ex. D, p. 2; Pet. Ex. E, pp. 2-3.) Dr. Chevalier based his conclusion of

“encephalopathy” on his assumption that B.G.S., in the days immediately following those

vaccinations, suffered from a high fever, “convulsions, seizures, and other forms of ataxia,” and

was limp, and lethargic. (Pet. Ex. D, p. 2; Pet. Ex. E, p. 2.) He also wrote that at one point

during those days B.G.S. was “generally unresponsive to any external stimuli.” (Pet. Ex. E, p.

2.)

However, while, B.G.S. clearly did suffer from a high fever of up to 104° (Pet. Ex. A, pp.

34-35), those other statements are not confirmed by the medical records of Dr. Chevalier’s own

office, created when B.G.S. visited on both March 30 and 31, 2005. Those medical records

make no mention of seizures, convulsions, or unusual seizure – like movements. The records do

not mention that B.G.S. was limp, lethargic, appeared to suffer from ataxia, or was unresponsive

to stimuli. (Pet. Ex. A, pp. 34-35; Pet. Ex. F, pp. 2-3.) Thus, Dr. Chevalier seems to have based

his conclusion of an “encephalopathy” upon severely mistaken assumptions of fact as to B.G.S.’s

symptoms.

Moreover, Dr. Chevalier also relied upon the allegation that B.G.S. was admitted to a

hospital with the symptoms alleged above, on March 30, 2005. (Pet. Ex. D, p. 2; Pet. Ex. E, p.

2.) But again, B.G.S.’s medical records show no such hospitalization. To the contrary, Dr.

Chevalier himself wrote on March 30 that B.G.S. was “happy and not in acute distress.” (Pet.

Ex. A, p. 34; Pet. Ex. F, p. 2.)

It appears, in this regard, that Dr. Chevalier may have been confusing two different

incidents and dates. That is, on March 30 of 2007, Dr. Chevalier examined B.G.S. due to a

recurrence of bilateral otitis media that had caused a two-day fever. (Pet. Ex. A, p. 41.) And

associated with that record is a hospital discharge summary from April 5, 2007. (Pet. Ex. A, pp.

55-56.)

Likewise, the Petitioners’ own contentions in their Petition, Amended Petition,

Prehearing Memorandum, and their attorney’s closing argument, concerning B.G.S.’s alleged

symptoms in the days immediately after the vaccinations of March 28, 2005, were generally

mistaken in the same way as the two reports of Dr. Chevalier.

Concerning this point, I have studied the affidavits of both the Petitioners (Ex. A, pp. 1-2)

and B.G.S.’s grandparents (filed on July 23, 2015), as well as the oral testimony given by all four

of those individuals during the evidentiary hearing on July 31, 2015. I do not find that the four

witnesses were intentionally misstating the facts as they remembered them. However, when I

compare the allegations of those four witnesses, given years after the vaccinations in question, to

the actual medical records made on March 30 and March 31, 2005, I must credit the records as

accurate, not the testimony.

In this regard, I note that medical records “warrant consideration as trustworthy

evidence.” Cucuras v. Sec'y of Health & Human Servs., 993 F.2d 1525, 1528 (Fed.Cir.1993).

11

At one point in his first report, Dr. Chevalier incorrectly stated that B.G.S. had received a “DTaP/HiB injection”

on March 28, 2005. (Ex. D, p. 2.) However, in his second report, Dr. Chevalier correctly described the vaccinations

of that day as Prevnar and Hib. (Ex. E, p. 2.)

18

Accordingly, where subsequent testimony conflicts with contemporaneous medical records,

special masters usually accord more weight to the medical records. See, e.g., Reusser v. Sec'y of

Health & Human Servs., 28 Fed. Cl. 516, 523 (Fed. Cl. 1993) (“[W]ritten documentation

recorded by a disinterested person at or soon after the event at issue is generally more reliable

than the recollection of a party to a lawsuit many years later.”).

To be sure, “it must [also] be recognized that the absence of a reference to a condition or

circumstance is much less significant than a reference which negates the existence of the

condition or circumstance. Since medical records typically record only a fraction of all that

occurs, the fact that reference to an event is omitted from the medical records may not be very

significant.” Murphy v. H.H.S., 23 Cl. Ct. 726, 733 (Fed. Cl. 1991), aff’d, 968 F.2d 1226 (Fed.

Cir. 1992).

However, in balancing these considerations, special masters in this Program have

traditionally declined to credit later testimony over contemporaneous records. See, e.g., Stevens

v. H.H.S, 90-221V, 1990 WL 608693, at *3 (Cl. Ct. Spec. Mstr. 1990); see also Vergara v.

H.H.S., 08-882V, 2014 WL 2795491, at *4 (Fed. Cl. Spec. Mstr. July 17, 2014) (“Special

Masters frequently accord more weight to contemporaneously-recorded medical symptoms than

those recorded in later medical histories, affidavits, or trial testimony.”) See also, Cucuras v.

H.H.S., 993 F.2d 1525, 1528 (Fed. Cir. 1993) (noting that “the Supreme Court counsels that oral

testimony in conflict with contemporaneous documentary evidence deserves little weight”).

Accordingly, the Petitioners’ causation-in-fact” allegation in this case must be rejected, in

the first place, for the simple reason that such allegation is based upon basic, very significant

misassumptions of fact as to what symptoms B.G.S. displayed during the days in question.12

B. Respondent’s expert was far more qualified, as to the particular medical issues at hand,

than Petitioners’ expert.

My discussion logically could end after Section VIII(A) above, since, as explained,

Petitioners’ causation theory is built upon significant misassumptions of fact. However, in the

interest of completeness, I will list some additional reasons why Petitioners’ causation theory is

clearly devoid of merit.

A second reason why Petitioners’ “causation-in-fact” theory is without merit, is simply

that I found Respondent’s expert, Dr. Bingham, to be far more qualified than the expert upon

whom Petitioners relied, Dr. Chevalier, to opine as to the particular medical issues involved in

this case.

Dr. Chevalier wrote that he is a board-certified pediatrician (Pet. Exs. D, E), which makes

him at least somewhat qualified to opine as to the issues here. But Dr. Bingham is much better

qualified. Dr. Chevalier’s theory is that B.G.S. suffered an encephalopathy, which is a

12

Petitioners have the burden of demonstrating the facts necessary for entitlement to an award by a “preponderance

of the evidence.” § 300aa-13(a)(1)(A). Under that standard, the existence of a fact must be shown to be “more

probable than its nonexistence.” In re Winship, 397 U.S. 358, 371 (1970) (Harlan, J., concurring).

19

neurological injury. And Dr. Bingham, unlike Dr. Chevalier, has had a long career as a pediatric

neurologist. (See Section V(B)(1), above.)

C. The written report of Petitioners’ expert did not even actually allege that B.G.S.’s vaccines

caused him any injury.

A close reading of the two written reports of Petitioners’ expert reveals that those reports

did not even actually allege that any vaccines caused B.G.S. any injury.

To be sure, Dr. Chevalier, in both his reports, opined clearly (if unconvincingly – see

Section VIII(D) of this Decision below) that B.G.S. suffered an “encephalopathy,” that the first

signs of that encephalopathy commenced within 72 hours of his vaccinations of March 28, 2005

(Pet. Ex. D, p. 2; Pet. Ex. E, p. 3), and that B.G.S. suffered “irreversible injury” which occurred

“proximate” to his Hib and Prevnar vaccinations of March 28 (Pet. Ex. E, p. 2).

But, Dr. Chevalier never stated explicitly that the vaccinations caused the

“encephalopathy,” and/or the “irreversible injury.” Nor did Dr. Chevalier ever state explicitly

that the encephalopathy caused B.G.S.’s autism, or his unspecified “irreversible injury,” or any

other condition.

I do conclude that one can plausibly infer, as I do, that Dr. Chevalier was implying that

the vaccinations of March 28, 2005, caused the “encephalopathy”/”irreversible injury” that Dr.

Chevalier alleged. I also infer that Chevalier was implying that the alleged encephalopathy in

turn caused B.G.S.’s severe neurodevelopmental disorder (i.e., his autism), and that Dr.

Chevalier meant “irreversible injury” to mean that neurodevelopmental disorder.

But, it is still noteworthy that Dr. Chevalier for some reason failed even to make a

straightforward statement to that effect in either of his written opinions.

D. Dr. Bingham’s opinion was more persuasive than that of Dr. Chevalier.

As I noted in Section VIII(C) of this Decision immediately above, based upon the totality

of Dr. Chevalier’s two written reports, it is fair to infer that Dr. Chevalier was opining that the

vaccinations of March 28, 2005, caused B.G.S. to suffer an “encephalopathy”/”irreversible

injury,” which, in turn, caused his tragic neurodevelopmental disorder, which has been diagnosed

as a disorder within the autism spectrum. But even inferring that that is Dr. Chevalier’s opinion,

I must reject that opinion, for several reasons. First, as explained above in Section VIII(A) of

this Decision, Dr. Chevalier’s opinion was based on gross misassumptions of fact concerning

B.G.S.’s symptom history. Second, explained above in Section VIII(B) of this Decision, Dr.

Chevalier’s qualifications concerning this issue are inferior to those of Respondent’s expert, Dr.

Bingham. And third, I found Dr. Bingham’s written report to be substantially more persuasive

than Dr. Chevalier’s written reports. Dr. Bingham found that there was no support in the

medical records to indicate that an encephalopathy had occurred soon after the vaccinations of

March 28, 2005. (R. Ex. A, pp. 4-6.) Dr. Bingham, for example, found no mention in the

records of the hospitalization that Dr. Chevalier assumed. (Id. at 5.) Additionally, Dr. Bingham

noted the presence of an abnormally rapid head growth in the 97th percentile in B.G.S.’s first

20

year of life, as a recognized marker of possible abnormal brain development, often seen in the

setting of autism. (Id. at 5.)

Dr. Bingham also highlighted the marked inconsistencies in symptomatology experienced

by B.G. S. as reflected in the medical records, as compared to Dr. Chevalier’s assumptions. (R.

Ex. A, pp. 5-6.)

Dr. Bingham’s review of the medical records also found no notes regarding

developmental or neurological concerns until July 2006, more than one year after the

vaccinations of March 28, 2005.

Further, Dr. Bingham opined that in the medical records, he saw no evidence of vaccine-

caused injury to B.G.S. (R. Ex. A, pp. 4-6). Dr. Bingham noted that a biochemical genetic

diagnostic evaluation done by Dr. Bock on April 7, 2009, “did not imply any consideration of

vaccine-related encephalopathy.” On April 29, 2009, pediatric neurologist Dr. Parker saw

B.G.S., with her impression being “static” encephalopathy, which, Dr. Bingham noted, did not

imply that B.G.S. had ever experienced an acute encephalopathy. (Id., pp. 3-4.)

In short, Dr. Bingham’s analysis of the case was much more persuasive than that of Dr.

Chevalier.

E. Other injuries

In their Petition, Amended Petition, and other documents, Petitioners have alleged that

B.G.S. suffered from not only a neurodevelopmental disorder, but also gastrointestinal problems,

metabolic disorders, and food allergies.

Dr. Chevalier’s opinions, however, did not address those other alleged disorders.

Petitioners have filed no evidence at all linking such disorders to any vaccinations. Accordingly,

I conclude that Petitioners have failed to demonstrate that B.G.S. suffers from any vaccine-

caused injury.

IX

PETITIONERS HAVE FAILED THE ALTHEN TEST

As noted above, in its ruling in Althen, the U.S. Court of Appeals for the Federal Circuit

discussed the “causation-in-fact” issue in Vaccine Act cases. The court stated as follows:

Concisely stated, Althen’s burden is to show by preponderant evidence that the

vaccination brought about her injury by providing: (1) a medical theory causally

connecting the vaccination and the injury; (2) a logical sequence of cause and

effect showing that the vaccination was the reason for the injury; and (3) a

showing of a proximate temporal relationship between the vaccination and injury.

If Althen satisfies this burden, she is “entitled to recover unless the [government]

21

shows, also by a preponderance of the evidence, that the injury was in fact caused

by factors unrelated to the vaccine.”

Althen, 418 F.3d 1274, 1278 (Fed. Cir. 2005) (citations omitted). In the pages above, of course, I

have already set forth in detail my analysis in rejecting Petitioners’ “causation-in-fact” theory in

this case. In this part of my Decision, then, I will briefly explain how that analysis fits

specifically within the three parts of the Althen test, enumerated in the first sentence of the

Althen excerpt set forth above. The short answer is that I find that Petitioners’ theory in this case

clearly does not satisfy the Althen test.

A. Relationship between Althen Prongs 1 and 2

One interpretive issue with the Althen test concerns the relationship between the first two

elements of that test. The first two prongs of the Althen test, as noted above, are that the

petitioners must provide “(1) a medical theory causally connecting the vaccination and the

injury; [and] (2) a logical sequence of cause and effect showing that the vaccination was the

reason for the injury.” Initially, it is not absolutely clear how the two prongs differ from each

other. That is, on their faces, each of the two prongs seems to require a demonstration of a

“causal” connection between “the vaccination” and “the injury.” However, a number of Program

opinions have concluded that these first two elements reflect the analytical distinction that has

been described as the “can cause” vs. “did cause” distinction. That is, in many Program opinions

issued prior to Althen involving “causation-in-fact” issues, special masters or judges stated that a

petitioner must demonstrate (1) that the type of vaccination in question can cause the type of

injury in question, and also (2) that the particular vaccination received by the specific vaccinee

did cause the vaccinee’s own injury. See, e.g., Kuperus v. HHS, 2003 WL 22912885, at *8 (Fed.

Cl. Spec. Mstr. Oct. 23, 2003); Helms v. HHS, 2002 WL 31441212, at *18 n. 42 (Fed. Cl. Spec.

Mstr. Aug. 8, 2002). Thus, a number of judges and special masters of this court have concluded

that Prong 1 of Althen is the “can cause” requirement, and Prong 2 of Althen is the “did cause”

requirement. See, e.g., Doe 11 v. HHS, 83 Fed. Cl. 157, 172-73 (2008); Nussman v. HHS, 83

Fed. Cl. 111, 117 (2008); Banks v. HHS, 2007 WL 2296047, at *24 (Fed. Cl. Spec. Mstr. July

20, 2007); Zeller v. HHS, 2008 WL 3845155, at *25 (Fed. Cl. Spec. Mstr. July 30, 2008). And,

most importantly, the Federal Circuit confirmed that interpretation in Pafford, ruling explicitly

that the “can it?/did it?” test, used by the special master in that case, was equivalent to the first

two prongs of the Althen test. Pafford v. HHS, 451 F.3d at 1352, 1355-56 (Fed. Cir. 2006).

Thus, interpreting the first two prongs of Althen as specified in Pafford, under Prong 1 of Althen

a petitioner must demonstrate that the type of vaccination in question can cause the type of

condition in question; and under Prong 2 of Althen that petitioner must then demonstrate that the

particular vaccination did cause the particular condition of the vaccinee in question.

Moreover, there can be no doubt whatsoever that the Althen test ultimately requires that,

as an overall matter, a petitioner must demonstrate that it is “more probable than not” that the

particular vaccine was a substantial contributing factor in causing the particular injury in

question. That is clear from the statute itself, which states that the elements of a petitioner’s case

must be established by a “preponderance of the evidence.” § 300aa-13(a)(1)(A). And, whatever

is the precise meaning of Prongs 1 and 2 of Althen, in this case the overall evidence falls far short

of demonstrating that it is “more probable than not” that any of the vaccines that B.G.S. received

22

contributed to the causation or aggravation of B.G.S.’s tragic neurodevelopmental disorder, or

any other injury.

B. Petitioners have failed to establish Prong 1 of Althen in this case

As explained above, under Prong 1 of Althen a petitioner must provide a medical theory

demonstrating that the type of vaccine in question can cause the type of condition in question.

Petitioners’ primary theory is that the vaccinations B.G.S. received on March 28, 2005, resulted

in various neurological, gastrointestinal, metabolic, and allergic conditions. However, as

described above in Section VIII, Dr. Chevalier has not demonstrated that the vaccinations can

cause any such injuries. Thus, Petitioners’ claim clearly fails under Althen Prong 1.

C. Petitioners have failed to establish Prong 2 of Althen in this case

Under Prong 2, the Petitioners need to show that it is “more probable than not” that one

or more of B.G.S.’s vaccinations did cause B.G.S.’s own condition. But this they have failed to

do, for all of the reasons detailed above, again in Section VIII. Dr. Chevalier did not even

provide a theory as to how the vaccinations in question might have caused B.G.S.’s alleged

encephalopathy. Further, as described in Section VIII(A) above, Dr. Chevalier relied upon gross

misassumptions concerning the facts of B.G.S.’s case. In addition, as described in Section

VIII(D), Dr. Bingham persuasively refuted Dr. Chevalier’s arguments concerning B.G.S.’s case.

Thus, Petitioners have failed to establish Prong 2 of Althen in this case.

D. Petitioners have failed to establish Prong 3 of Althen in this case

Since I have explained why Petitioners have failed to satisfy the first and second prongs

of Althen, I need not discuss why Petitioners’ case also fails to satisfy the third prong. However,

Dr. Chevalier’s above-described factual misassumptions mean that Petitioners have not been able

to establish any proximate temporal relationship between any vaccination and any injury, as

required under Althen Prong 3.

E. This is not a close case

In Althen the Federal Circuit indicated that the Vaccine Act involves a “system created by

Congress, in which close calls regarding causation are resolved in favor of injured claimants.”

418 F.3d at 1280. Accordingly, I note here that this case ultimately is not a close case. For all

the reasons set forth above, I found that Dr. Chevalier’s opinion and Petitioners’ arguments were

not at all persuasive, while Respondent’s expert was far more persuasive.

23

X

NOTATION CONCERNING “REASONABLE BASIS” OF CASES ALLEGING THAT

VACCINATIONS AFFECTED AUTISM SPECTRUM DISORDERS (ASDs)

In this case Petitioners’ counsel may or may not ultimately seek an award of attorneys’

fees and costs. If counsel does so, I will then decide whether there was a reasonable basis to file

this case and to prosecute it through trial to a decision.

My notation here, rather, concerns the general issue of whether future Vaccine Act cases

involving ASDs, prosecuted to the point of a special master decision, will be found to have a

“reasonable basis,” so as to qualify for an award of attorneys’ fees and costs. I note that there

currently exist on my docket a number of cases in which it is alleged that a vaccinee’s ASD was

caused or aggravated by a vaccination. In many similar cases, in light of the “test cases”

described on pp. 4-5 above, either the petitioner filed a “Motion for a Decision Dismissing the

Petition,” or the attorney withdrew from the case. In such situations, I have been inclined to find

that the petition had a “reasonable basis” at the time of filing, and that it was reasonable to

prosecute the petition up to a certain point in time.

However, in many other cases since the “test cases” became final in 2010, petitioners

have elected to proceed to an evidentiary hearing, or have sought a “Ruling on the [written]

Record,” requiring a special master to spend a large amount of time evaluating the petitioner’s

theory and deciding the case. See decisions listed at pp. 5-6, above. In all of those cases, the

petitioners have fallen far short of presenting a viable theory that one or more vaccines of any

kind can contribute to causing or aggravating an ASD. Those failures have included cases in

which the petitioner’s theory is that the vaccination caused an “encephalopathy” (brain injury),

which encephalopathy in turn allegedly affected the ASD; and cases in which the petitioners

have alleged that the vaccinee had a “mitochondrial disorder” or “mitochondrial dysfunction,”

which allegedly made the vaccinee more susceptible to injury by vaccination.

In short, since the “test cases,” all efforts in Vaccine Act cases to causally connect

vaccines to ASD have fallen far short of plausibility.13 The cases have presented no plausible

evidence at all that vaccines can contribute to the causation of autism.

However, those cases have absorbed a huge amount of time of several special masters,

time that could have been spent on other, more potentially viable, Vaccine Act cases. For

example, in one case, R.K. v. HHS, Special Master Vowell was required to prepare two separate

opinions, one of 161 pages and one of 58 pages (both single-spaced).

13

I am not ignoring the Poling and Wright cases discussed at footnote 4 above. In each of those unusual cases, as

explained in footnote 4, the vaccinee was shown to have suffered a Table Injury, presumed to be vaccine-caused

under the Vaccine Act. But no finding of causation was made. Indeed, in the Wright case, while finding a Table

Injury, Special Master Vowell remarked that the petitioner’s alternative “causation-in-fact” theory in that case was

“absurd.”

24

Therefore, Vaccine Act counsel are hereby put on notice that if counsel pursue, to a

decision, theories allegedly linking vaccines causally to ASDs,14 and their evidence proves to be

highly unpersuasive, I will not be inclined to conclude that there was a “reasonable basis” to

pursue such cases to a decision. At this point, I cannot ethically award government funds to

compensate counsel for pushing clearly unpersuasive theories to a decision.

In other words, I strongly advise counsel in Vaccine Act cases to carefully scrutinize, for

credibility, any cases in which a petitioner or an expert witness asserts a theory that a vaccination

significantly contributed to the causation or aggravation of an ASD. If after deciding such a

case, I am not persuaded that there was a “reasonable basis,” under all of the circumstances, for

pushing the case to a special master decision, I will be unlikely to award fees and costs, including

the cost of experts, for the evidentiary hearing or the final stages of the proceeding.

XI

CONCLUSION

The record of this case demonstrates plainly that B.G.S. and his family have been through

a tragic ordeal. I had the opportunity, during the evidentiary hearing, to observe B.G.S.’s

parents. I have also studied the records describing B.G.S.’s medical history, and the efforts of

his family in caring for him. Based upon those experiences, the great dedication of B.G.S.’s

family to his welfare is readily apparent to me.

Nor do I doubt that B.G.S.’s parents are sincere in their belief that B.G.S.’s vaccinations

played a role in causing B.G.S.’s autism and/or other medical conditions. B.G.S.’s parents have

heard the opinion of Dr. Chevalier, and perhaps other physicians, who profess to believe in a

causal connection between vaccines and autism. After studying the extensive evidence in this

case, I am convinced that the opinion provided by Petitioners’ expert in this case, advising the

Sturdivant family that there is a causal connection between the vaccinations B.G.S. received and

B.G.S.’s medical condition, was quite wrong. Nevertheless, I can understand why B.G.S.’s

parents found such opinion to be believable under the circumstances. I conclude that the

Petitioners filed this petition in good faith.

Thus, I feel deep sympathy for the Sturdivant family. Further, I find it unfortunate that

my ruling in this case means the Program will not be able to provide funds to assist this family,

in caring for their child who suffers from a serious disorder. It is my view that our society does

not provide enough assistance to families of all autistic children, regardless of the cause of their

disorders. And it is certainly my hope that our society will find ways to ensure that in the future

much more generous assistance is available to all such children. Such families must cope every

day with tremendous challenges in caring for their autistic children, and all are deserving of

sympathy and admiration. However, I must decide this case not on sentiment, but by analyzing

the evidence. Congress designed the Program to compensate only the families of individual

whose injuries or deaths can be linked causally, either by Table Injury presumption or by

14

This includes theories alleging a Table Injury in which the medical records contain no significant evidence of a

Table Injury.

25

preponderance of “causation-in-fact” evidence, to a listed vaccine. In this case, the evidence

advanced by Petitioners has fallen far short of demonstrating such a link. Accordingly, I

conclude that the Petitioners in this case are not entitled to a Program award on B.G.S.’s behalf.15

IT IS SO ORDERED.

/s/ George L. Hastings, Jr.

George L. Hastings, Jr.

Special Master

15

In the absence of a timely-filed motion for review of this Decision, the Clerk of the Court shall enter judgment

accordingly.

26